(Click to view former Editorial Board members.)
Editor-In-Chief
|
Raymond P Roos MD* Disclosures: Dr. Roos serves on the Scientific Advisory Board of Revalesio Corporation and a Drug Monitoring Board for a gene therapy study of Sarepta Therapeutics. He has also received consulting fees from Best Doctors and Guidepoint Network, and holds shares in Amgen, Merck, Ionis, and Express Scripts. |
Senior Associate Editors
|
Emma Ciafaloni MD FAAN Disclosures: Dr. Ciafaloni received personal compensation for serving on advisory boards and/or as a consultant for Avexis, Biogen, Pfizer, PTC Therapeutics, Sarepta, Ra pharma, Wave, and Strongbridge Biopharma; and for serving on a speaker’s bureau for Biogen. Dr Ciafaloni also received research and/or grant support from Orphazyme, PTC Therapeutics, Santhera, and Sarepta. |
|
Antonio Culebras MD FAAN FAHA FAASM* Disclosures: Dr. Culebras received an honorariums from Jazz Pharmaceuticals for a speaking engagements. |
|
Darryl De Vivo MD Disclosures: Dr. De Vivo has no relevant financial relationships to disclose. |
|
Salvatore DiMauro MD Disclosures: Dr. DiMauro has no relevant financial relationships to disclose. |
|
Edward Dropcho MD Disclosures: Dr. Dropcho has no relevant financial relationships to disclose. |
|
Jerome Engel Jr MD PhD Disclosures: Dr. Engel received honorariums from Cerebel for advisory committee membership. |
|
Randolph W Evans MD Disclosures: Dr. Evans received honorariums from Allergan, Amgen, Biohaven, Lilly, Novartis, and Teva for speaking engagements. |
|
Martin Farlow MD Disclosures: Dr. Farlow received research grant support from AbbVie, Biogen, Boehringer Ingelheim, Eisai, Eli Lilly, Genentech, Roche, Novartis, Suven Life Sciences Ltd, and vTv Therapeutics; fees from Cerecin/Accera, Allergan, Avanir, AZ Therapies, Eli Lilly, Kyowa Kirin Pharma, Longeveron, Medavante, Merck, Neurotrope Biosciences, Proclara, Takeda, and vTv Therapeutics for consultancy, or advisory board/DSMB membership; licensing fees from Elan; and consulting fees from Cortexyme, Green Valley, Regenera, Samumed, Zhejiang Hisun Pharmaceuticals, Cognition Therapeutics, Danone, Eisai, and Otsuka. |
|
James Goodwin MD Disclosures: Dr. Goodwin has no relevant financial relationships to disclose. |
|
Francesc Graus MD PhD* Disclosures: Dr. Graus has no relevant financial relationships to disclose. |
|
John E Greenlee MD Disclosures: Dr. Greenlee received consulting fees from Sommers Schwartz for review of medical records. |
|
Joseph Jankovic MD* Disclosures: Dr. Jankovic received research and training funding from Allergan, F Hoffmann-La Roche, Medtronic Neuromodulation, Merz, Neurocrine Biosciences, Nuvelution, Revance, and Teva and consulting/advisory board honorariums from Abide, Lundbeck, Retrophin, Parexel, Teva, and Allergan. |
|
Michael V Johnston MD Disclosures: Dr. Johnston has no relevant financial relationships to disclose. |
|
Howard S Kirshner MD Disclosures: Dr. Kirshner received fees from Biogen for consulting work. |
|
Peter J Koehler MD PhD Disclosures: Dr. Koehler has no relevant financial relationships to disclose. |
|
Douglas J Lanska MD FAAN MS MSPH* Disclosures: Dr. Lanska has no relevant financial relationships to disclose.. |
|
Steven R Levine MD Disclosures: Dr. Levine has no relevant financial relationships to disclose. |
|
Rimas V Lukas MD Disclosures: Dr. Lukas received honorariums from Novocure for speaking engagements, honorariums from Novocure for advisory board membership, and research support from BMS. |
|
Bernard L Maria MD MBA Disclosures: Dr. Maria has no relevant financial relationships to disclose. |
|
Christina M Marra MD Disclosures: Dr. Marra has no relevant financial relationships to disclose. |
|
Roger Packer MD Disclosures: Dr. Packer received honorariums from AstraZeneca and Novartis as an advisory board member. |
|
Deric M Park MD Disclosures: Dr. Park has no relevant financial relationships to disclose. |
|
Harvey B Sarnat MD Disclosures: Dr. Sarnat has no relevant financial relationships to disclose. |
|
Raphael Schiffmann MD Disclosures: Dr. Schiffmann received research grants from Amicus Therapeutics, Protalix Biotherapeutics, and Sanofi Genzyme. |
|
Nina Schor MD PhD* Disclosures: Dr. Schor has no relevant financial relationships to disclose. |
|
Stephen D Silberstein MD Disclosures: Dr. Silberstein receives honorariums from Abbie, Curelator, Ipsen Therapeutics, Lundbeck Biopharmaceuticals, Supernus Pharmaceuticals, and Theranica for consulting. He is also the principal investigator for clinical trials conducted by Amgen, ElectroCore Medical, and Teva. |
|
Jonathan D Trobe MD Disclosures: Dr. Trobe has no relevant financial relationships to disclose. |
|
Louis H Weimer MD Disclosures: Dr. Weimer has received consulting fees from Roche. |
|
Barry Wolf MD PhD Disclosures: Dr. Wolf has no relevant financial relationships to disclose. |
Associate Editors
|
Robert Fekete MD Disclosures: Dr. Fekete received consultation fees from Acadia, Acorda, Adamas, Amneal/Impax, Kyowa Kirin, Lundbeck, Neurocrine, and Teva. |
|
Jennifer Friedman MD Disclosures: Dr. Friedman has no relevant financial relationships to disclose. |
|
James G Greene MD PhD Disclosures: Dr. Greene has no relevant financial relationships to disclose. |
|
Michio Hirano MD* Disclosures: Dr. Hirano has no relevant financial relationships to disclose. |
|
Michael J Howell MD Disclosures: Dr. Howell received grant support from Apnex and GE and honorariums from Inspire as a panel member. |
|
AHM Mahbubul Huq MD PhD Disclosures: Dr. Huq has no relevant financial relationships to disclose. |
|
K K Jain MD Disclosures: Dr. Jain has no relevant financial relationships to disclose. |
|
Matthew Lorincz MD PhD Disclosures: Dr. Lorincz of the University of Michigan received honorariums from Alexion for advisory board service. |
|
Victor W Mark MD Disclosures: Dr. Mark has no relevant financial relationships to disclose. |
|
Solomon L Moshé MD Disclosures: Dr. Moshé received received consulting fees from Pfizer and UCB. |
|
Heather Moss MD PhD Disclosures: Dr. Moss has no relevant financial relationships to disclose. |
|
C P Panayiotopoulos MD PhD† Disclosures: Dr. Panayiotopoulos has no relevant financial relationships to disclose. |
|
Federica Provini MD PhD Disclosures: Dr. Provini received speakers' fees from Italfarmaco and Pfizer. |
|
Amy A Pruitt MD Disclosures: Dr. Pruitt has no relevant financial relationships to disclose. |
![]() |
Anthony T Reder MD Disclosures: Dr. Reder received honorariums from Bayer, Biogen Idec, Caremark Rx, Genentech, Genzyme, Novartis, Mallinckrodt, Mylan, Serono, and Teva-Marion for service on advisory boards and as a consultant as well as stock options from NKMax America for advisory work. |
|
Joseph R Siebert PhD Disclosures: Dr. Siebert has no relevant financial relationships to disclose. |
|
John M Stern MD Disclosures: Dr. Stern received honorariums from Eisai, Greenwich, SK Life Sciences, and UCB Pharma as an advisor and from Eisai, Greenwich, LivaNova, Neurelis, and UCB Pharma as a lecturer. |
|
Christina Ulane MD PhD Disclosures: Dr. Ulane received a consulting fee and travel expenses from Roche as a meeting consultant. |
|
Aravindhan Veerapandiyan MD Editorial Board Member since 2019: Neuromuscular Disorders Disclosures: Dr. Veerapandiyan has no relevant financial relationships to disclose. |
|
Shuu-Jiun Wang MD Disclosures: Dr. Wang received consulting fees from Eli Lilly and Novartis for advisory board membership and honorariums from AbbVie as a speaker. |
† Deceased
Former Editors
Click to view former Editorial Board members.